# Enanta Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/enanta-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Watertown, US
- Website: www.enanta.com
- Total disclosed funding: $20M
- Latest round: Series B (Jul 1, 2000)
- Investors on record: 5

## About

Founded in 1995, Enanta Pharmaceuticals, Inc. is a research and development-focused biotechnology company thatuses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field.

## Funding rounds

- Series B, Jul 1, 2000, $20M — Advent International, Vontobel Asset Management (Private Wealth), Oxford Bioscience Partners, AlpInvest Partners, TVM Capital Life Science

## Investors

- Advent International (https://capitalatlas.ai/funds/advent-international) — Series B
- Vontobel Asset Management (Private Wealth) (https://capitalatlas.ai/funds/vontobel-asset-management-private-wealth) — Series B
- Oxford Bioscience Partners (https://capitalatlas.ai/funds/oxford-bioscience-partners) — Series B
- AlpInvest Partners — Series B
- TVM Capital Life Science (https://capitalatlas.ai/funds/tvm-capital-life-science) — Series B